GSK enters exclusive collaboration with SBP Group to accelerate hepatitis B treatment in China

GSK plc has entered into an exclusive strategic collaboration with Sino Biopharmaceutical (SBP Group), through its subsi...

May 13, 2026 | Wednesday | News
Taiwan's Bora Group buys MacroGenics' GMP manufacturing operations for $122.5 M

Taiwan-based Bora Pharmaceuticals announced that its Board of Directors has approved the acquisition of the GMP manufact...

May 12, 2026 | Tuesday | News
CEL-SCI enters strategic agreement with Amarox for commercialisation and distribution of Multikine in Saudi Arabia

US-baed CEL-SCI Corporation has signed a strategic partnership, distribution, and revenue sharing agreement with&nb...

May 12, 2026 | Tuesday | News
Hengrui Pharma and Bristol Myers Squibb to advance innovative medicines across oncology, hematology, immunology

China-based Hengrui Pharma and Bristol Myers Squibb (BMS) have announced the companies have entered into globa...

May 12, 2026 | Tuesday | News
Japan's Daiichi Sankyo unveils five-year business plan focused on oncology innovation

Japan-based Daiichi Sankyo has revealed its next Five-Year Business Plan (FY2026 - FY2030) that outlines how the company...

May 11, 2026 | Monday | News
China's SiranBio inks $1 B deal with GSK for metabolic and vascular disease treatment

Suzhou Siran Biotechnology has announced a worldwide exclusive license agreement with GSK (excluding mainland China, Hon...

May 8, 2026 | Friday | News
Waiv enters collaboration with Daiichi Sankyo to deliver AI-derived biomarkers for ADC programme

Waiv, formerly Owkin Dx, a Paris-based company catalysing artificial intelligence (AI) precision testing, has entered a ...

May 7, 2026 | Thursday | News
SGS launches GMP-compliant NMR testing for Chinese pharma industry

SGS, world’s leading Testing, Inspection and Certification company, has expanded its analytical capabilities in Ch...

May 7, 2026 | Thursday | News
Basel Area Business & Innovation inks new collaboration with Korean biopharma companies

Basel Area Business & Innovation, the strategic growth partner helping ventures in science and tech to land, launch ...

May 6, 2026 | Wednesday | News
UAE’s LIFEPharma signs MoU with AD Ports for $190 M pharma manufacturing platform

LIFEPharma, a part of VPS Healthcare and the UAE’s only USFDA-approved manufacturer, has signed a memorandum of un...

May 6, 2026 | Wednesday | News
Holista executes binding JV for collagen facility in Australia

Holista Colltech has entered into a binding Joint Venture (JV) agreement with Swang Chai Chuan (SCC) for the funding, de...

May 6, 2026 | Wednesday | News
Australia approves small interfering RNA medicine for Familial Chylomicronemia Syndrome

US-based Arrowhead Pharmaceuticals has announced that the Australian Therapeutic Goods Administration&nbs...

May 5, 2026 | Tuesday | News
Rockwell Automation and Cytiva join hands to accelerate digital transformation for biopharma companies

Cytiva, a Danaher company and a leader in the life sciences industry, and Rockwell Automation, Inc, the world&rsquo...

May 4, 2026 | Monday | News
Japan's Shionogi joins World Economic Forum and signs Davos Compact on Antimicrobial Resistance

Japan-based Shionogi & Co. has joined the World Economic Forum (WEF), and signed the Davos Compact on Antimicrobial ...

May 1, 2026 | Friday | News
China's Huahui Health and BeOne Medicines ink $1.9 B oncology deal

China-based startup Huahui Health has entered into a global exclusive option, license and collaboration agreement w...

May 1, 2026 | Friday | News
Taiwan's Formosa Pharma and Singapore Eye Research Institute partner to advance novel ophthalmic formulations for corneal diseases

Taiwan-based Formosa Pharmaceuticals, Inc. and the Singapore Eye Research Institute (SERI) have annoounced a strategic r...

May 1, 2026 | Friday | News
Emirates Drug Establishment gives nod to first nasal epinephrine spray

The Emirates Drug Establishment (EDE) has officially granted approval for EURneffy®, a novel epinephrine-based treat...

April 30, 2026 | Thursday | News
Ravidasvir receives approval in Thailand for treatment of Hepatitis C

In a historic step for the Egyptian pharmaceutical industry that reinforces its global leadership, the Thai Food and Dru...

April 30, 2026 | Thursday | News
Arcera Life Sciences inks long-term collaboration framework with Fosun Pharma

Arcera Life Sciences, a global life sciences company headquartered in Abu Dhabi, and Shanghai Fosun Pharmaceutical Group...

April 29, 2026 | Wednesday | News
China gives marketing approval to world's first recombinant Botulinum Toxin Type A drug

Chongqing Claruvis Pharmaceutical, a subsidiary of MingMed Biotechnology, has announced that the China's National M...

April 29, 2026 | Wednesday | News
IMG Pharma enters into definitive agreement to acquire Matsumoto Pharmaceutical in Japan

IMG Pharmaceutical Co, a majority-owned subsidiary of IMG Japan, the Group's holding company, has entered into a definit...

April 27, 2026 | Monday | News
India and New Zealand sign historic Free Trade Agreement

India and New Zealand signed the India-New Zealand Free Trade Agreement (IN-NZ FTA) at Bharat Mandapam in New Delhi, on ...

April 27, 2026 | Monday | News
Novartis malaria treatment Coartem® Baby receives WHO prequalification

Novartis has announced that the World Health Organization (WHO) has prequalified Coartem® (artemether-lumefantrine) ...

April 26, 2026 | Sunday | News
AbbVie's largest-ever capital investment of $1.4 B to build pharma manufacturing campus in US

AbbVie has announced a $1.4 billion investment to build a 185-acre pharmaceutical manufacturing campus in Durham, N...

April 24, 2026 | Friday | News
Jamjoom Pharma and Caritas Egypt launch strategic partnership to enhance eye healthcare

Jamjoom Pharma, one of the fastest-growing pharmaceutical companies in Saudi Arabia and across MEA, has announced the si...

April 23, 2026 | Thursday | News